Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Lammering

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
European Journal of Medical Research|February 5, 2014
Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot studyChristiane Matuschek, Marcus Lehnhardt, Peter Arne Gerber, et al.
Diseases of the Colon and Rectum|November 10, 2011
Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapyDoenja M J Lambregts, Monique Maas, Frans C H Bakers, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 4, 2010
The use of FDG-PET to target tumors by radiotherapyGuido Lammering, Dirk De Ruysscher, Angela van Baardwijk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 21, 2009
The deletion mutant EGFRvIII significantly contributes to stress resistance typical for the tumour microenvironmentJan Theys, Barry Jutten, Ludwig Dubois, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 19, 2010
Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: sequential perfusion-CT findingsMarco H M Janssen, Hugo J W L Aerts, Roel G J Kierkels, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2006
Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infiltration in rectal cancerCoen I M Baeten, Karolien Castermans, Guido Lammering, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 2, 2010
Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findingsMarco H M Janssen, Michel C Ollers, Ruud G P M van Stiphout, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 28, 2012
FDG-PET-CT reduces the interobserver variability in rectal tumor delineationJeroen Buijsen, Jørgen van den Bogaard, Hiska van der Weide, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
PET-based treatment response evaluation in rectal cancer: prediction and validationMarco H M Janssen, Michel C Öllers, Ruud G P M van Stiphout, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 24, 2010
Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancerMarco H M Janssen, Michel C Ollers, Ruud G P M van Stiphout, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Medical Research|February 5, 2014
Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot studyChristiane Matuschek, Marcus Lehnhardt, Peter Arne Gerber, et al.
Diseases of the Colon and Rectum|November 10, 2011
Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapyDoenja M J Lambregts, Monique Maas, Frans C H Bakers, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 4, 2010
The use of FDG-PET to target tumors by radiotherapyGuido Lammering, Dirk De Ruysscher, Angela van Baardwijk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 21, 2009
The deletion mutant EGFRvIII significantly contributes to stress resistance typical for the tumour microenvironmentJan Theys, Barry Jutten, Ludwig Dubois, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 19, 2010
Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: sequential perfusion-CT findingsMarco H M Janssen, Hugo J W L Aerts, Roel G J Kierkels, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2006
Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infiltration in rectal cancerCoen I M Baeten, Karolien Castermans, Guido Lammering, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 2, 2010
Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findingsMarco H M Janssen, Michel C Ollers, Ruud G P M van Stiphout, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 28, 2012
FDG-PET-CT reduces the interobserver variability in rectal tumor delineationJeroen Buijsen, Jørgen van den Bogaard, Hiska van der Weide, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
PET-based treatment response evaluation in rectal cancer: prediction and validationMarco H M Janssen, Michel C Öllers, Ruud G P M van Stiphout, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 24, 2010
Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancerMarco H M Janssen, Michel C Ollers, Ruud G P M van Stiphout, et al.
Pageof 8